Objective:

To evaluate the effectiveness of the Radiomics-based Early Detection Model (REDMOD) in detecting pancreatic ductal adenocarcinoma earlier than traditional imaging methods.

Key Findings:

• REDMOD achieved an AUC of 0.82 with a sensitivity of 73.0% and specificity of 81.1%, indicating a strong potential for clinical application.
• The AI model's sensitivity was significantly higher than that of radiologists, which was 38.9%, highlighting the need for AI integration in early detection.
• Detection rates improved with longer lead times, with REDMOD showing 68.0% sensitivity more than 24 months before diagnosis, suggesting a critical window for intervention.

Interpretation:

REDMOD demonstrates superior performance in detecting early-stage pancreatic ductal adenocarcinoma compared to expert radiologists, indicating its potential as a transformative tool for proactive cancer interception and improved patient outcomes.

Limitations:

• Prospective validation is necessary to confirm clinical utility across diverse populations.
• The study's findings are based on a specific dataset, which may introduce biases and require further validation to ensure generalizability.

Conclusion:

The REDMOD framework represents a significant advancement in early detection of pancreatic ductal adenocarcinoma, potentially shifting the diagnostic paradigm from late-stage detection to early intervention, ultimately improving patient outcomes.